Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2019
WuXi Biologics and Convalife partner on bispecific antibody development
WuXi Biologics and Convalife announced a collaboration to develop an innovative anti-tumor bispecific antibody. Convalife will use WuXi Biologics' integrated biopharmaceutical capabilities, while WuXi Biologics will provide technical support for discovery, development and manufacturing.